StockData

Milestone Scientific vs Jin Medical International

MLSS and ZJYL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MLSS and ZJYL compare

Milestone Scientific grew revenue faster over the last twelve months (3.7% versus −12.0% for Jin Medical International).

Jin Medical International keeps more of each dollar of sales as profit, with a net margin of 5.8% compared with −44.0% at Milestone Scientific.

Milestone Scientific scores higher on the StockData Score (7 against 3 for Jin Medical International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMLSSZJYL
Size and price
Market cap$24.6M–
Share price$0.277$3.38
Change, 1 year−16.1%−34.0%
Change, 5 years−88.9%–
Beta (5Y)1.630.19
Employees1540
StockData Score
Total score7 (better)3
Valuation score1 (better)0
Growth score00
Performance score12 (better)
Health score5 (better)1
Dividend score00
Valuation
P/S2.6×–
P/B7.1×–
FCF yield−2.7%–
Fair value$0.337–
Margin of safety17.8%–
Growth
Revenue growth (TTM)3.7% (better)−12.0%
Revenue growth, 5Y average10.5%–
Net income growth (TTM)–−67.6%
EPS growth (TTM)–−50.0%
Profitability
Gross margin70.2% (better)29.2%
Operating margin−43.6%2.9% (better)
Net margin−44.0%5.8% (better)
FCF margin−7.0% (better)−18.0%
Return on equity−122%4.1% (better)
Return on invested capital−152%3.1% (better)
Financial health
Debt / equity0.000.69 (better)
Net debt / EBITDA–−10.87
Current ratio1.851.95 (better)
Altman Z-score−19.69–
Piotroski F-score34 (better)
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions5.3%0.01%
Held by insiders21.6%8.3%
Insider net buying, 12 months$0–
Short interest, % of float0.11%0.01%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.